Nov 23, 2017
Senseonics Announces Eversense CGM System Achieves High-Level Accuracy Results from US Pivotal Study
The company, a healthcare organization developing and commercializing the continuous glucose monitoring (CGM) system in patients with diabetes, today announced high-accuracy results in PRECISE II (Prospective, multicenter evaluation of the Continuous Glucose Sensor) clinical trial.
Results from 90 adults with diabetes generated 16,000 comparative glucose data points and showed high accuracy over…
View On WordPress